An established German medical cannabis importer, exporter, and distributor with a strong sales network into German pharmacies and global markets is looking for a strategic equity partner to accelerate growth and expand operations. The company is open to full divestiture.
Business Highlights:
- Licensed wholesaler handling dried flower, extracts, finished medical cannabis products, and API in bulk and jars. Services include white labeling, in-house branding, and B2B/B2C sales.
- Operates from licensed, leased premises with integrated office and lab space for imports and a partner processing and storage facility.
- Expert team with deep knowledge of German, European, and global medical cannabis markets, as well as opportunities in recreational cannabis.
- Differentiated digital infrastructure and online assets provide a competitive edge in the German market.
- Increasing supplier network and expanded product portfolio to meet growing market demand.
- Efficient, self-funded operation with a low monthly burn rate and no debt.
- Positive cash-flow, with projected revenues of €2.7 million in 2024 and €4.5 million in 2025.
Key Opportunities:
- Tap into Germany’s evolving cannabis market, simplified by the 2024 reclassification of cannabis as non-narcotic.
- Utilize existing licenses to perform research on psychedelics.
- Collaborate with suppliers as a launchpad for white-label packaging, distribution, and market entry into Germany.
- Strategic partner or merger opportunity to scale operations and meet increasing clientele demands across Europe.
This is a rare opportunity to invest in or acquire a thriving medical cannabis distributor positioned at the forefront of the German and European cannabis markets.
